North Carolina Poison Control Issues Important GLP-1 Drug Safety Alert
A recent study by North Carolina Poison Control reveals a concerning trend in the use of GLP-1 drugs. The study found that the center receives an average of one to two calls per day regarding these medications, with a staggering 80% of those calls involving mistakes in administration. This highlights a critical need for public awareness and education about the safe use of GLP-1 drugs.
GLP-1 drugs, primarily used to treat diabetes and obesity, have gained immense popularity in recent years. Brands like Ozempic, Wegovy, Trulicity, and Mounjaro are widely prescribed and available in tablet or injection forms. However, the study's findings indicate that many users are encountering issues with their medication.
Common mistakes identified in the study include taking the wrong dosage, administering doses too close together, and giving the medication to the wrong family member. While most cases result in mild outcomes, the potential for serious complications exists, emphasizing the importance of understanding and following proper usage guidelines.
Dr. Michael Beuhler, Medical Director of NC Poison Control, emphasizes the need for informed decision-making. He advises, "People should be informed, not fearful, about GLP-1 medications. It's crucial to understand the prescribed dose and potential complications with your healthcare provider. Ensure you know how to measure and self-administer the medication to avoid an overdose."
To prevent GLP-1 medication poisoning, NC Poison Control offers the following recommendations:
- Read the medication label carefully, noting that starting and maintenance doses differ.
- Establish a consistent routine for self-administration, as some GLP-1 medications are taken daily, while others are weekly.
- Adhere to the prescribed dosage; do not attempt to expedite results by taking more than recommended, as it may lead to adverse effects.
- Recognize that GLP-1 drugs are not interchangeable; only take the medication prescribed to you.
The FDA also warns the public about the dangers of obtaining GLP-1 drugs from online compounding pharmacies. Compounding involves customizing medications by altering or combining ingredients, which may occur during drug shortages or when patients require a specific formulation not approved by the FDA. These compounded drugs are not subject to FDA safety or effectiveness evaluations, and the FDA strongly advises against purchasing them from online sources due to potential quality issues.
For individuals experiencing symptoms related to GLP-1 medication, NC Poison Control provides a dedicated helpline: 1-800-222-1222, or you can chat with a representative at www.NCPoisonControl.org. This resource is invaluable for anyone seeking guidance or assistance with GLP-1 drug usage.
Copyright 2026 Capitol Broadcasting Company
